AIHTA - Publications - Search - Browse by Type
Number of items: 155.

Arrich, J. and Piribauer, F. and Mad, P. and Schmid, D. (2005): Intra-articular hyaluronic acid for the treatment of osteoarthritis of the knee: Systematic review and meta-analysis. CMAJ: Canadian Medical Association Journal 172 (8): pp. 1039-1043.

Busse, R. and Orvain, J. and Velasco-Garrido, M. and Perleth, M. and Drummond, M. and Wild, C. (2002): Best practice in undertaking and reporting health technology assessment. International Journal of Technology Assessment in Health Care 18 (02): pp. 361-422.

Eder, C. and Wild, C. (2019): Advanced Therapy Medicinal Products (ATMPs): Technology forecast. Journal of Market Access & Health Policy 7 (1).

Falkner, E. and Eder, C. (2007): Health technology assessment: Evaluation of costs and benefits of therapies & methods. Int. J. Artif. Org. 2007. (In Press)

Falkner, E. and Eder, C. and Wild, C. (2007): Evaluation of regenerative medicine/tissue engineering approaches by health technolgy assessment. Regenerative Medicine 2007. (In Press)

Felder-Puig, R. (2007): [The future of clinical studies?]. Österreichische Ärztezeitung (12): pp. 48-49.

Felder-Puig, R. (2007): [Therapeutic conversation: The effectiveness of intensified physician-patient communication]. Newsletter der Österreichischen Gesellschaft für Public Health (01): p. 2.

Felder-Puig, R. and Mad, P. and Gartlehner, G. (2007): [Diagnostic studies]. WMW: Wiener Medizinische Wochenschrift 2007. (In Press)

Gartlehner, G. and Wild, C. and Mad, P. (2008): [Systematic reviews and meta-analyses]. WMW: Wiener Medizinische Wochenschrift 158 (3-4): pp. 127-133.

Gebetshuber, I. and Ratzer, B. and Wild, C. (1997): [Biomedical research projects and socio-scientific issues] . Soziale Technik (1): pp. 12-15.

Gebetshuber, I. and Ratzer, B. and Wild, C. (1997): [Biomedical research projects and socio-scientific issues]. TA-Datenbank-Nachrichten 06 (02): pp. 36-41.

Guba, B. (2008): [Systematic literature search]. WMW: Wiener Medizinische Wochenschrift 158 (01-02): pp. 62-69.

Guba, B. (2007): [Library services in university portals: Outlook and risks]. VÖB-Mitteilungen 60 (2): pp. 30-38.

Guba, B. (2006): [Libraries and portals - a survey]. Medizin Bibliothek Information 6 (2).

Jonas, S. and Jessner, W. and Rafetseder, O. and Wild, C. (2005): [Chronic hepatitis C in Austria]. Mitteilungen der Sanitätsverwaltung 01: pp. 5-7.

Jonas, S. and Rafetseder, O. and Wild, C. (2005): [Colorectal cancer screening in Austria: Integrating coloscopy into the preventive medical check up]. Journal für Gastroenterologische und hepatologische Erkrankungen 03: pp. 11-15.

Jonas, S. and Wild, C. and Schamberger, C. (2003): [Predictive genetic testing for breast and colorectal cancer]. ZaeFQ: Zeitschrift für ärztliche Fortbildung und Qualitätssicherung 97 (01): pp. 67-71.

Jonas, S. and Wild, C. and Schamberger, C. (2002): Predictive genetic testing for mammary and colorectal cancer. Wiener Klinische Wochenschrift 114 Suppl. (17-18): p. 24.

Knapp, M. and Mc Daid, D. and Amaddeo, F. and Zechmeister, I. (2007): Financing Mental Health Care in Europe. Journal of Mental Health 16 (02): pp. 167-180.

Krebs, E.E. and Gaynes, B.N. and Gartlehner, G. and Hansen, R.A. and Thieda, P. and Morgan, L.C. and de Veaugh-Geiss, A. and Lohr, K.N. (2008): Treating the physical symptoms of depression with second-generation antidepressants: A systematic review and metaanalysis. Psychosomatics: The Journal of Consultation and Liaison Psychiatry 49 (3): pp. 191-198.

Mad, P. and Domanovits, H. and Fazelnia, C. and Stiassny, K. (2007): Human heart-type fatty-acid-binding protein as a point-of-care test in the early diagnosis of acute myocardial infarction. QJM: An International Journal of Medicine 100 (4): pp. 203-210.

Mad, P. and Felder-Puig, R. and Gartlehner, G. (2007): [Randomized controlled trials]. WMW: Wiener Medizinische Wochenschrift April 2007. (In Press)

Mathis, S. and Gartlehner, G. (2008): [Cohort studies]. WMW: Wiener Medizinische Wochenschrift 158 (05-06): pp. 174-179.

Puig, S. and Felder-Puig, R. (2006): [Evidence-based radiology: A new approach to evaluate the clinical practice of radiology]. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren 178 (7): pp. 671-679.

Puig, S. and Staudenherz, A. and Felder-Puig, R. and Paya, K. (2008): Imaging of appendicitis in children and adolescents: Useful or useless? A comparison of imaging techniques and a critical review of the current literature. Seminars in Roentgenology 43 (1): pp. 22-28.

Wild, C. (2006): [Austrian HTA institute founded]. ITA-Newsletter June 2006: pp. 9-10.

Wild, C. (2005): [Targeted therapies]. ITA-Newsletter September 2005: pp. 11-12.

Wild, C. (2005): [Advance directives: Comment of the Viennese Bioethics Commission]. ITA-Newsletter September 2005: pp. 12-13.

Wild, C. (2005): [Foundation of an Austrian HTA institute]. ITA-Newsletter March 2005: p. 2.

Wild, C. (2004): [Genetic testing for predisposition]. ITA-Newsletter December 2004: p. 8.

Wild, C. (2004): [HTAi annual meeting in Krakow]. ITA-Newsletter September 2004: pp. 11-13.

Wild, C. (2004): [The Oregon drug class review project as initiative for generics]. ITA-Newsletter September 2004: p. 13.

Wild, C. (2004): [HTA´s role in the maintenance of a health care system based on solidarity]. ITA-Newsletter June 2004: p. 10.

Wild, C. (2003): [Guidance for manufacturers and medical associations on submission of evidence]. ITA-Newsletter December 2003: p. 9.

Wild, C. (2003): [HTA and the commercialisation of new technologies] . ITA-Newsletter December 2003: pp. 10-11.

Wild, C. (2003): [HTA in hospitals]. ITA-Newsletter September 2003: pp. 9-10.

Wild, C. (2003): [Clinical economics]. ITA-Newsletter September 2003: pp. 10-11.

Wild, C. (2003): [Decision making: A systematic checklist]. ITA-Newsletter September 2003: p. 11.

Wild, C. (2003): [Evaluating organisational performance: Quantitative and qualitative methods]. ITA-Newsletter March 2003: p. 9.

Wild, C. (2002): [Rationing in health care]. ITA-Newsletter December 2002: p. 8.

Wild, C. (2002): [New anti-cancer drugs]. ITA-Newsletter December 2002: p. 9.

Wild, C. (2002): [Meeting the needs of intensive care]. ITA-Newsletter September 2002: p. 5.

Wild, C. (2002): [ISTAHC 2002: Trends and tendencies]. ITA-Newsletter September 2002: p. 10.

Wild, C. (2002): [Guidance for manufacturers and medical associations on submission of evidence]. ITA-Newsletter September 2002: p. 11.

Wild, C. (2002): [Critical journalism: Evidence-based reporting of innovations]. ITA-Newsletter March 2002: p. 8.

Wild, C. (2001): [Innovations and (expensive) followers]. ITA-Newsletter December 2001: p. 9.

Wild, C. (2001): [Project on generics: Saving 5 million schilling]. ITA-Newsletter December 2001: p. 10.

Wild, C. (2001): [Limits of the evidence-based medicine: Conflicts of interests]. ITA-Newsletter December 2001: p. 10.

Wild, C. (2001): [HTA newsletter]. ITA-Newsletter December 2001: p. 11.

Wild, C. (2001): [Stem cells: Quo vadis?]. ITA-Newsletter September 2001: pp. 8-9.

Wild, C. (2001): [European HTA project comes to an end in September]. ITA-Newsletter September 2001: pp. 10-11.

Wild, C. (2001): [IOM report "To Err is Human"]. ITA-Newsletter March 2001: pp. 8-9.

Wild, C. (2001): [International symposium on health technology assessment]. ITA-Newsletter March 2001: p. 9.

Wild, C. (2000): [ISTHAC 2002 in Berlin]. ITA-Newsletter September 2000: p. 8.

Wild, C. (2000): [The C-reactive protein test in the diagnosis of infections]. ITA-Newsletter September 2000: p. 3.

Wild, C. (2000): [EPO for cancer related anaemia]. ITA-Newsletter April 2000: p. 5.

Wild, C. (2000): [HTA and decision making]. ITA-Newsletter April 2000: p. 6.

Wild, C. (1999): [National insurance in Germany and Swiss: Removal of ineffective medical services from the individual medical services catalogue]. ITA-Newsletter October 1999: pp. 20-21.

Wild, C. (1998): [HTA as steering tool]. ITA-Newsletter October 1998: pp. 20-21.

Wild, C. (1998): [European collaboration in health technology assessment (ECHTA)]. ITA-Newsletter October 1998: pp. 20-21.

Wild, C. and Antes, G. (2004): [Registration of all clinical trials]. ITA-Newsletter December 2004: p. 13.

Wild, C. and Goldgruber, R. (2004): [Assessment of non-ionic contrast media]. ITA-Newsletter March 2004: p. 4.

Wild, C. and Goldgruber, R. (2004): [Non-commercial clinical trials]. ITA-Newsletter March 2004: pp. 10-11.

Wild, C. and Groth, S. (2003): . ITA-Newsletter March 2003: p. 8.

Wild, C. and Jonas, S. (2001): [Immunoglobulins in transplant medicine: Prevention and therapy of cytomegalovirus infections]. ITA-Newsletter September 2001: pp. 9-10.

Wild, C. and Jonas, S. (2000): [HTA-workshop of European social insurance agencies]. ITA-Newsletter December 2000: p. 8.

Wild, C. and Jonas, S. (2000): [Symposium "Evidence-based Medicine"]. ITA-Newsletter December 2000: pp. 8-9.

Wild, C. and Jonas, S. (2000): [EPO in cancer anaemia]. ITA-Newsletter September 2000: pp. 2-3.

Wild, C. (2008): Polymorphism-screening: genetic testing for predisposition - guidance for technology assessment. Poiesis & Praxis: International Journal of Ethics of Science and Technology Assessment 05 (01): pp. 1-14.

Wild, C. (2007): [FDA: Safety warning on erythropoietin]. ÖKZ: Österreichische Krankenhauszeitung 48 (07).

Wild, C. (2007): [Drug eluting stents. Status quo]. ÖKZ: Österreichische Krankenhauszeitung 48 (03).

Wild, C. (2007): [Horizon scanning]. ÖKZ: Österreichische Krankenhauszeitung 48 (04): p. 16.

Wild, C. (2007): [Funding programme of the Vienna Science and Technology Fund (WWTF)]. ÖKZ: Österreichische Krankenhauszeitung 48 (01): p. 16.

Wild, C. (2006): [Foundation of the Ludwig Boltzmann Institute Health Technology Assessment]. Technikfolgen-Abschätzung – Theorie & Praxis 03 (15): pp. 77-79.

Wild, C. (2006): [Critical scientific methods for evaluating the effects of medical interventions]. Der Anaesthesist 55 (05): pp. 568-577.

Wild, C. (2006): [EUnetHTA - 2006-2008]. ITA-Newsletter March 2006: p. 7.

Wild, C. (2006): [Non-ionic contrast media]. ÖKZ: Österreichische Krankenhauszeitung 47 (7/8): p. 16.

Wild, C. (2006): [Foundation of a HTA institute in Austria]. ÖKZ: Österreichische Krankenhauszeitung 47 (6): p. 16.

Wild, C. (2006): [EUnetHTA: A network of HTA agencies in Europe]. ÖKZ: Österreichische Krankenhauszeitung 47 (11): p. 17.

Wild, C. (2006): [Generics vs. brand name drugs after patent expiration] . ÖKZ: Österreichische Krankenhauszeitung 47 (10): p. 16.

Wild, C. (2006): [Acute care for older persons: A multi-disciplinary approach]. ÖKZ: Österreichische Krankenhauszeitung 47 (04): p. 16.

Wild, C. (2006): [Proton therapy]. ÖKZ: Österreichische Krankenhauszeitung 47 (03): p. 19.

Wild, C. (2006): [Neuromodulation for Parkinson´s disease and chronic pain]. ÖKZ: Österreichische Krankenhauszeitung 47 (02): p. 16.

Wild, C. (2005): Ethics of Resource Allocation: Instruments for rational decision-making in support of a sustainable health care. Poiesis & Praxis: International Journal of Ethics of Science and Technology Assessment 03 (04): pp. 296-309.

Wild, C. (2005): [Health technology assessment: An introduction]. Newsletter des NÖ-Patientenanwalts April 2005.

Wild, C. (2005): [Robot assisted surgery]. ÖKZ: Österreichische Krankenhauszeitung 46 (12): p. 11.

Wild, C. (2005): [Vertebroplasty and kyphoplasty]. ÖKZ: Österreichische Krankenhauszeitung 46 (11): p. 18.

Wild, C. (2005): [Health technology assessment]. ÖKZ: Österreichische Krankenhauszeitung 46 (10): p. 50.

Wild, C. (2005): [Avastin®/Bevacizumab for metastatic colorectal cancer]. ÖKZ: Österreichische Krankenhauszeitung 46 (10): p. 51.

Wild, C. (2005): [The Medical Association´s policy and evidence-based medicine]. Qualitas 12 (04): p. 11.

Wild, C. (2005): [Priority setting for the assessment of medical interventions]. Mitteilungen der Sanitätsverwaltung 5: pp. 9-11.

Wild, C. (2004): [HTAi annual meeting in Krakow]. ÖKZ: Österreichische Krankenhauszeitung 45 (7/8): pp. 34-35.

Wild, C. (2004): [The myth of cancer prevention: Heresy or guidance to maturity]. ÖKZ: Österreichische Krankenhauszeitung 45 (4): pp. 10-11.

Wild, C. (2004): [The Austrian health care system]. CliniCum (1-2): p. 54.

Wild, C. (2004): [HTAi annual meeting in Krakow]. ZaeFQ: Zeitschrift für ärztliche Fortbildung und Qualitätssicherung 98: p. 556.

Wild, C. (2003): [Erythropoietin: The impact of HTA] . Mitteilungen der Sanitätsverwaltung 104 (9): p. 23.

Wild, C. (2003): [Erythropoietin: The impact of HTA]. ÖKZ: Österreichische Krankenhauszeitung 44 (12): pp. 9-10.

Wild, C. (2002): Erythropoietin in tumor anemia - for whom is effective?. International Journal of Cancer 13 (Supplement): p. 70.

Wild, C. (2002): [Is critical journalism contradictory to the reporting of innovations?]. ZaeFQ: Zeitschrift für ärztliche Fortbildung und Qualitätssicherung (96): p. 336.

Wild, C. (2001): Screening in Austria - the cases of mammography, PSA-testing and routine use of ultrasonography in pregnancy. International Journal of Technology Assessment in Health Care 17 (03): pp. 305-315.

Wild, C. (2001): [Assessing medical interventions: Erythropoietin in tumour anaemia]. TA-Datenbank-Nachrichten (01, Sonderheft): pp. 51-55.

Wild, C. (2001): [Assessing medical interventions]. ManagMed (3).

Wild, C. (2000): [HTA and decision making]. TA-Datenbank-Nachrichten 09 (04): pp. 152-153.

Wild, C. (2000): Country report: Health technology assessment in Austria. International Journal of Technology Assessment in Health Care 16 (02): pp. 303-324.

Wild, C. (2000): [Erythropoietin in patients with fatigue syndrome]. forum dr. Med. (13): pp. 4-5.

Wild, C. (2000): [Health technology assessment: A steering tool]. Mitteilung der Sanitätsverwaltung (01): pp. 6-8.

Wild, C. (1999): HTA in Austria: PACS and ESWT. Medical and Biological Engineering & Computing (Supplement 4).

Wild, C. (1998): [What do Austrian experts think about health care?]. ManagMed (2): pp. 33-35.

Wild, C. (1998): [Neighbourly help]. Häusliche Pflege (12): pp. 33-41.

Wild, C. (1997): [Forecasting in medicine: expert opinions]. Das Gesundheitswesen 59: pp. 467-472.

Wild, C. (1997): [Patient organisations]. GID: Gen-ethischer Informationsdienst (6).

Wild, C. (1997): [Medical technology assessment (MTA)]. ÖKZ: Österreichische Krankenhauszeitung 38 (06).

Wild, C. (1994): [Housing adaptation in Austria and Germany]. Zeitschrift für Gerontologie 27 (06): pp. 381-389.

Wild, C. (1994): Experiences with counseling for housing adaption in Austria and Germany. Safety Alarm Systems, Technical Aids and Smart Homes (06): pp. 153-172.

Wild, C. (1994): [Safety alarm systems and housing adaptation with technical aids]. Berliner Pflege Blatt 1994.

Wild, C. (1993): [Gerontechnology: Technologies for the elderly]. Soziale Technik (2): pp. 15-16.

Wild, C. (1990): [The social implications of the increasing spread of technology in health care]. Journal für Sozialforschung 30 (03): pp. 294-317.

Wild, C. and Gartlehner, G. (2007): [Health technology assessment]. WMW: Wiener Medizinische Wochenschrift 2007. (Submitted)

Wild, C. and Gibis, B. (2002): Evaluations of health interventions in social insurance-based countries: Germany, the Netherlands, and Austria. Health Policy 63 (02): pp. 187-196.

Wild, C. and Jonas, S. (2003): [To what extent can the publicly sponsored health system afford predictive genetic diagnostics? - First approaches to pinpoint and limit responsibilities, exemplified by hereditary carcinomas]. Das Gesundheitswesen 65 (06): pp. 351-358.

Wild, C. and Jonas, S. (2002): [Predictive genetic testing for breast and colon cancer]. Newsletter der Österreichischen Gesellschaft für Public Health (3): p. 1.

Wild, C. and Jonas, S. (2001): [Health policy decisions between rationing and rationalisation as demonstrated by the example of erythropoietin in tumour anaemia]. Das Gesundheitswesen 63 (2): pp. 221-225.

Wild, C. and Jonas, S. (2000): [Erythropoietin (EPO) in tumour anaemia]. Newsletter der Österreichischen Gesellschaft für Public Health (4): pp. 1-2.

Wild, C. and Jonas, S. and Frank, W. and Schmetterer, L. and Sycha, T. (2002): [Immunoglobulins in transplant medicine. Prevention and therapy of cytomegalovirus infections: An Assessment]. Transplantationsmedizin (02): pp. 65-73.

Wild, C. and Jonas, S. and Frank, W. and Schmetterer, L. and Sycha, T. (2001): [Immunoglobulins in transplant medicine. Prevention and therapy of cytomegalovirus infections: An Assessment]. European Surgery: Acta Chirurgica Austriaca 33 (Supplement 178).

Wild, C. and Jonas, S. and Rafetseder, O. (2004): [Colon cancer screening]. Mitteilungen der Sanitätsverwaltung 11: pp. 14-15.

Wild, C. and Jonas, S. and Schamberger, C. (2003): Predictive genetic testing for hereditary cancer. Value in Health 6 (6): pp. 794-795.

Wild, C. and Jonas, S. and Schamberger, C. (2002): [Predictive genetic diagnostics for hereditary cancer]. Mitteilungen der Sanitätsverwaltung 01: pp. 6-8.

Wild, C. and Khene, M. and Wanke, S. (2000): ESWT: Extracorporeal shock wave therapy - Assessment of an emerging health technology. International Journal of Technology Assessment in Health Care 16 (01): pp. 199-209.

Wild, C. and Kirschner, A. (1994): [Safety alarm systems and housing adaptation: Technical aids for the elderly]. Häusliche Pflege (06): pp. 381-389.

Wild, C. and Langer, T. (2008): EU-wide newsletter on emerging technologies: Informing and supporting health policy early . Health Policy 2008. (In Press)

Wild, C. and Mikl, M. (1996): [Medical genetics in Austria: Opportunities and risks]. Soziale Technik (3): pp. 6-8.

Wild, C. and Mikl, M. (1996): [Medical genetics in Austria]. Journal für Sozialforschung 36 (01): pp. 87-108.

Wild, C. and Narath, M. (2005): Evaluating and planning ICUs: Methods and approaches to differentiate between need and demand. Health Policy 71 (03): pp. 289-301.

Wild, C. and Narath, M. (2003): [Evidence-based intensive care planning. A systematic review of recent ICU-plans and planning approaches]. Intensivmedizin und Notfallmedizin 40 (05): pp. 412-419.

Wild, C. and Narath, M. (2002): [Evidence-based ICU bed planning]. Mitteilungen der Sanitätsverwaltung 01: pp. 9-12.

Wild, C. and Peissl, W. (1992): Patient cards: An assessment of a new information technology in health care. Project Appraisal 7 (2): pp. 67-78.

Wild, C. and Peissl, W. and Tellioglu, H. (1998): An Assessment of PACS: The Case Study of the SMZO Project. International Journal of Technology Assessment in Health Care 14 (03): pp. 573-582.

Wild, C. and Perleth, M. (2001): Possibilities for partial integration of Health Technology Assessment (HTA) and Technology Assessment (TA). TA-Datenbank-Nachrichten 10 (01): pp. 55-58.

Wild, C. and Perleth, M. (2001): [Health technology assessment: An introduction]. TA-Datenbank-Nachrichten 10 (01): pp. 6-12.

Wild, C. and Puig, S. (2004): [Me-too pharmaceuticals - Marketing-strategies of drug producers and drug purchasers. Example: Non-ionic contrast media]. Das Gesundheitswesen 66 (11): pp. 716-722.

Wild, C. and Schimetta, W. (2005): [Application studies]. ITA-Newsletter December 2005: pp. 5-6.

Wild, C. and Torgersen, H. (2000): Forecasting in medicine: The results of three European Delphi Studies. European Journal of Public Health 10 (02): pp. 114-119.

Wild, C. and Wanke, S. (1999): [Extracorporeal shock wave therapy: An assessment]. ÖKZ: Österreichische Krankenhauszeitung 40 (03): pp. 20-21.

Wild, C. and Zechmeister, I. (2007): [Theories of distributional justice in health care and the role of HTA]. Kurswechsel 2: pp. 87-88.

Zechmeister, I. (2008): [HPV-vaccination in Austria. A prediction on long-term effects and costs]. Biomed Austria (Frühling 2008): pp. 8-9.

Zechmeister, I. (2006): [Cost-effectiveness of statins]. ITA-Newsletter March 2006: p. 3.

Zechmeister, I. (2006): [Health policy between 2002 and 2006 – what is the experts’ opinion?]. ÖKZ: Österreichische Krankenhauszeitung 47 (09): p. 8.

Zechmeister, I. (2006): [Women, think economically?! Ambivalences of current economic thinking. The case of health economics]. Beiträge zur Feministischen Theorie und Praxis 68: pp. 115-127.

Zechmeister, I. (2005): [Financing health care: Challenges for psychiatry]. ITA-Newsletter December 2005: pp. 4-5.

Zechmeister, I. and Kilian, R. and Mc Daid, D. (2008): Is it worth investing in mental health promotion and prevention of mental illness? A systematic review of the evidence from economic evaluations. BMC Public Health 08 (20).

Zechmeister, I. and Radlberger, P. (2007): [Health economic evaluation]. WMW: Wiener Medizinische Wochenschrift 2007. (Submitted)

Zechmeister, I. and Wild, C. and Langer, T. and Koller, D. (2007): [Neonatal care of low-risk newborns by paediatricians. An approach to evidence-based health care planning]. Monatsschrift Kinderheilkunde July 2007. (Submitted)

Zechmeister, I. and Österle, A. (2007): [Informal care of people with mental disorders: Does the Austrian long-term care system provide adequate support?]. Neuropsychiatrie 21 (1): pp. 29-36.

Zechmeister, I. and Österle, A. (2006): Distributional impacts of mental health care financing arrangements: A comparison of the UK, Germany and Austria. Journal of Mental Health Policy and Economics 9 (1): pp. 34-44.

This list was generated on Mon Oct 7 22:00:14 2024 CEST.